The ESMO Congress 2026 is set to feature several potentially important immunotherapy readouts across solid tumors. From ...
Rethinking Menopause Care Across the Breast Cancer Journey / Breast Cancer, cancer, Lisa Larkin, Lynn Sage Breast Cancer ...
A New Model for Tumor-Agnostic Immunotherapy Reimbursement / cancer, cancer immunotherapy, immunotherapy, ipilimumab, ...
SCRI Oncology Partners Supports Breast Cancer Awareness in Nashville / Breast Cancer, cancer, Erika Hamilton, MORE THAN PINK, ...
Earlier Multiple Myeloma Diagnosis Starts With Primary Care / C. Ola Landgren, cancer, Myeloma, National Cancer Institute, ...
Exploring New Directions in EGFR-Mutant NSCLC at ESMO26 / Antonio Calles, Antonio Passaro, cancer, David Planchard, ...
Bringing Visibility to the Often-Overlooked Phase of Breast Cancer Survivorship / Breast Cancer, breast cancer awareness ...
What Makes Early-Onset Colorectal Cancer Biologically Different? / cancer, colorectal cancer, EOCRC, Fusobacterium nucleatum, ...
Closing Childhood Cancer Awareness Month With Purpose and Passion / cancer, Childhood Cancer, Childhood Cancer Awareness ...
Adjuvant Immunotherapy after complete NSCLC resection: a 2026 systematic review estimates the absolute 36-month DFS benefit ...
A randomized trial found that a 12-month exercise intervention was associated with slower epigenetic aging and cognitive ...
FDA Approval Opens New Treatment Path for ESR1-Mutated Breast Cancer / Abemaciclib, Breast Cancer, cancer, EMBER-3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results